Leo Niskanen

Researcher Next ID · RN-007333

Researcher · Medicine

Joensuu, Finland

Not currently recruitingFunding unknown

Research interests

Medicine

Diabetes, Cardiovascular Risks, and Lipoproteins

Diabetes Treatment and Management

Diabetes Management and Research

Diabetes Management and Education

Diet and metabolism studies

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
International Journal of Obesity · 2011 · https://doi.org/10.1038/ijo.2011.158
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)60742-x
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)61375-1
Testosterone and Sex Hormone–Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men
Diabetes Care · 2004 · https://doi.org/10.2337/diacare.27.5.1036
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
The Lancet · 1999 · https://doi.org/10.1016/s0140-6736(98)05012-0

No projects listed.